Unravel Health joins SBC to drive innovation in women’s hormonal health

The team has taken space in the Lab Hotel as they develop technology that helps women better understand hormone patterns linked to fertility, menstrual cycles and wider wellbeing.

Stevenage Bioscience Catalyst is pleased to welcome Unravel Health to campus as the team settles into the SBC Lab Hotel. The company specialises in improving access to personalised hormonal insights, supporting women in navigating fertility and other areas of health that are often overlooked or misunderstood.

Unravel Health is developing technology that translates complex biological signals into clear information, enabling women to better understand how their individual hormone patterns relate to their wellbeing. By offering greater clarity during key life stages, the company aims to empower women with data that has historically been difficult to obtain, track or interpret.

The company is led by CEO and Founder Liza Levy, supported by Simon Jackson, Eithar Mohamed and Veronica Bridgman, who joined SBC this month.

Liza says:
“We are really pleased to join Stevenage Bioscience Catalyst and bring Unravel Health into this community. Having a base that is close to both London and Cambridge works well for our team, and being part of such a dynamic, forward thinking campus is a great place for us to build the next stage of our work in women’s health.”

Unravel Health joins a thriving community of innovators working across health and life sciences at SBC. The team will now benefit from a supportive ecosystem that includes shared facilities, peer networks and opportunities to engage with industry and investors.

If you would like to know more about Unravel Health or if you are interested in space opportunities at SBC, please contact Marco Delise.